Biocept Funding & Investors
Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests. Biocept serves patients and customers in the State of California.
biocept.comTotal Amount Raised: $48,200,000
Biocept Funding Rounds
Post Ipo Equity
$5,000,000
Post Ipo Equity
$14,800,000
Post Ipo Equity
$9,300,000
Post Ipo Equity Investors
Roth Capital PartnersChardan CapitalDebt Financing
$1,200,000
Series B
$2,299,999
Series A
$3,600,000
Series Unknown
$10,000,000
Series Unknown Investors
Needham Capital PartnersSeries Unknown
$2,000,000
Funding info provided by Diffbot.